In fact, as in the case of QFT-GIT, the sensitivity of T-SPOT.TB in one study was higher in patients with CD4+ cells <200 (90%; 95% CI 67–99) than in those with CD4+ cells ≥200 cells (78%; 95% CI 52–94) [31]. The gene discussed is CD4; the disease is tuberculosis.